Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM21A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | DENND4B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | GK | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | ZBTB17 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | FER1L5 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | DMRT2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | PABPN1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | LARS2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | CALM3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | ARID1B | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |